TITLE

Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure

AUTHOR(S)
Meves, Katia R.; Graciolli, Fabiana G.; Dos Reis, Luciene M.; Pasqualucci, Carlos A.; Moysés, Rosa M. A.; Jorgetti, Vanda
PUB. DATE
December 2004
SOURCE
Kidney International;Dec2004, Vol. 66 Issue 6, p2237
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure.Background. Hyperphosphatemia and disturbances in calcium or parathyroid hormone (PTH) metabolism contribute to the high incidence of cardiovascular disease and renal osteodystrophy in chronic renal failure (CRF). We evaluated the effect of hyperphosphatemia on the cardiovascular system, on renal function, and on bone in experimental uremia.Methods. Wistar rats were submitted to parathyroidectomy (PTx) and 5/6 nephrectomy (Nx) with minipump implantation, delivering 1-34 rat PTH (physiologic rate), or were sham-operated and received vehicle. Only phosphorus content (low-phosphorus (LP) 0.2%; high-phosphorus (HP) 1.2%) differentiated diets. We divided the groups as follows: PTx+Nx+LP; sham+ LP; PTx+ Nx+ HP; and sham+ HP. Tail-cuff pressure and weight were measured weekly. After 2 months, biochemical, arterial, and myocardial histology and bone histomorphometry were analyzed.Results. Heart weight normalized to body weight (heart weight/100 g body weight) was higher in PTx+ Nx+ HP rats (PTx+ Nx+ HP= 0.36± 0.01 vs. sham+ HP= 0.29± 0.01, PTx+ Nx+ LP= 0.32± 0.01, sham+ LP= 0.28± 0.01) (P<0.05). Serum creatinine levels were higher in PTx+ Nx+ HP rats than in PTx+ Nx+ LP rats (1.09± 0.13 vs. 0.59± 0.03 mg/dL) (P<0.05). Levels of PTH did not differ significantly between the groups. Myocardial and arterial histology detected no vascular calcification or fibrosis. Bone histomorphometry revealed an association, unrelated to uremia, between HP diets and decreased trabecular connectivity.Conclusion. Myocardial hypertrophy, impaired renal function, and adverse effects on bone remodeling were associated with hyperphosphatemia and were not corrected by PTH replacement. Although no vascular calcification was observed in this model, we cannot rule out an adverse effect of hyperphosphatemia on the vascular bed. Our finding underscores the importance of phosphorus control in reducing morbidity and mortality in CRF patients.
ACCESSION #
15021212

 

Related Articles

  • Non-suppressible secondary hyperparathyroidism in chronic progressive renal disease. Slatopolsky, Eduardo; Rutherford, W. Ernest; Hoffstein, Phillip E.; Elkan, Ivan O.; Butcher, Harvey R.; Bricker, Neal S. // Kidney International;Jan1972, Vol. 1 Issue 1, p38 

    Secondary hyperparathyroidism is a frequent, and almost universal, concomitant of advancing chronic renal disease. When renal failure is of long standing, the degree of secondary hyperparathyroidism may be quite marked. Under such circumstances, short-term elevation of serum calcium...

  • Altered calcium metabolism in chronic renal failure. Letteri, Joseph M.; Ellis, Kenneth J.; Orofino, Donald P.; Ruggieri, Santos; Asad, Syed N.; Cohn, Stanton H. // Kidney International;Jul1974, Vol. 6 Issue 1, p45 

    A compartmental analysis of 47Ca tracer kinetic data and Ca balance measurements was employed to evaluate several indexes of Ca metabolism in patients with mild to severe renal insufficiency. Rates of Ca accretion and resorption and the size of the exchangeable Ca pools were measured. In...

  • Contrasting mammalian PTH promoters: identification of transcription factors controlling PTH gene expression. Koszewski, N. J.; Alimov, A. P.; Langub, M. C.; Park-Sarge, O.-K.; Malluche, H. H. // Clinical Nephrology;2005, Vol. 63 Issue 2, p158 

    Parathyroid hormone (PTH) is a key component in the maintenance of calcium and phosphate homeostasis. The steady-state expression of the PTH gene can be modeled as a balance between transcriptional activators and repressors. During renal failure, the gradual loss of kidney function is of ten...

  • The flavors of vitamin D: Tasting the molecular mechanisms. Goodman, William G. // Kidney International;Sep2004, Vol. 66 Issue 3, p1286 

    Comments on the biological function of vitamin D in the kidney tissues. Effects of Vitamin D in patient with chronic kidney disease; Details on the molecular mechanism of regulating the parathyroid gene expression in kidney disease; Outcome of the evaluation of the differences among the vitamin...

  • Ratio of parathyroid hormone to 1 ,25-dihydroxycholecalciferol in early renal failure. Lucas, Philip A.; Brown, Richard C.; Woodhead, J. Stuart; Coles, Gerald A. // Kidney International Supplement;Dec1983, Issue 16, pS171 

    The article reports on the results of a study of ratio of parathyroid hormone to 1,25-dihydroxycholecalciferol in chronic renal failure (CRF). A description of the experimental setup and measurement methods is given. The article explains why the precise degree of renal impairment at which...

  • Renal and hepatic uptake of biologically active intact parathyroid hormone. Heidbreder, Ekkehard; Götz, Rüdiger; Schafferhans, Klauss; Heidland, August // Kidney International Supplement;Oct1987, Issue 22, pS-221 

    Examines renal and hepatic uptake of biologically active intact parathyroid hormone (PTH). Influence of diseased kidneys on the peripheral metabolism of the intact hormone; Relationship between peripheral-venous PTH concentrations and total serum calcium in acute renal failure; Percentage renal...

  • A balanced view of calcium and phosphate homeostasis in chronic kidney disease. Evenepoel, Pieter; Wolf, Myles // Kidney International;May2013, Vol. 83 Issue 5, p789 

    The association of abnormalities of calcium and phosphate homeostasis with adverse clinical outcomes in chronic kidney disease (CKD) has generated interest in developing therapeutic strategies to target mineral metabolism early in the course of CKD. Hill et al. present results from a classic...

  • Parathyroid hormone assay: problems and opportunities. Martin, Kevin J.; González, Esther A. // Pediatric Nephrology;Oct2007, Vol. 22 Issue 10, p1651 

    The assay of parathyroid hormone continues to remain problematic as a result of the presence in the circulation of a variety of parathyroid hormone (PTH) peptides derived from secretion and from peripheral metabolism. The detection of these PTH fragments to varying degrees leads to widely...

  • Paricalcitol aggravates perivascular fibrosis in rats with renal insufficiency and low calcitriol. Repo, J. M.; Rantala, I. S.; Honkanen, T. T.; Mustonen, J. T.; Kööbi, P.; Tahvanainen, A. M.; Niemelä, O. J.; Tikkanen, I.; Rysä, J. M.; Ruskoaho, H. J.; Pörsti, I. H. // Kidney International;Oct2007, Vol. 72 Issue 8, p977 

    Cardiovascular complications are a major problem in chronic renal failure. We examined the effects of plasma calcium, phosphate, parathyroid hormone (PTH), and calcitriol on cardiac morphology in 5/6 nephrectomized rats. Fifteen weeks after nephrectomy rats were given a control diet,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics